Literature DB >> 20570410

[Other pharmacological dyslipidemia treatment options for raising HDL-cholesterol].

Manuel Frías Vargas, Juan Roberto Peraira Moral, Beatriz López Serrano.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20570410      PMCID： PMC7024456          DOI： 10.1016/j.aprim.2010.03.012

Source DB:  PubMed          Journal:  Aten Primaria        ISSN： 0212-6567            Impact factor:   1.137


× No keyword cloud information.
  6 in total

Review 1.  Thiazolidinediones.

Authors:  Hannele Yki-Järvinen
Journal:  N Engl J Med       Date:  2004-09-09       Impact factor: 91.245

2.  [Therapeutic drug option for dyslipaemia].

Authors:  Antonio Maiques Galan; Carlos Brotons Cuixart
Journal:  Aten Primaria       Date:  2009-06-04       Impact factor: 1.137

3.  Thiazolidinedione drugs and cardiovascular risks: a science advisory from the American Heart Association and American College of Cardiology Foundation.

Authors:  Sanjay Kaul; Ann F Bolger; David Herrington; Robert P Giugliano; Robert H Eckel
Journal:  Circulation       Date:  2010-02-23       Impact factor: 29.690

4.  Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.

Authors:  John A Dormandy; Bernard Charbonnel; David J A Eckland; Erland Erdmann; Massimo Massi-Benedetti; Ian K Moules; Allan M Skene; Meng H Tan; Pierre J Lefèbvre; Gordon D Murray; Eberhard Standl; Robert G Wilcox; Lars Wilhelmsen; John Betteridge; Kåre Birkeland; Alain Golay; Robert J Heine; László Korányi; Markku Laakso; Marián Mokán; Antanas Norkus; Valdis Pirags; Toomas Podar; André Scheen; Werner Scherbaum; Guntram Schernthaner; Ole Schmitz; Jan Skrha; Ulf Smith; Jan Taton
Journal:  Lancet       Date:  2005-10-08       Impact factor: 79.321

Review 5.  Thiazolidinediones in type 2 diabetes: a cardiology perspective.

Authors:  Ujjaini Khanderia; Rodica Pop-Busui; Kim A Eagle
Journal:  Ann Pharmacother       Date:  2008-09-02       Impact factor: 3.154

6.  Increased high-density lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intima-media thickness progression in patients with type 2 diabetes mellitus.

Authors:  Michael Davidson; Peter M Meyer; Steven Haffner; Steven Feinstein; Ralph D'Agostino; George T Kondos; Alfonso Perez; Zhen Chen; Theodore Mazzone
Journal:  Circulation       Date:  2008-04-14       Impact factor: 29.690
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.